This map shows the geographic impact of I Setnikar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I Setnikar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I Setnikar more than expected).
This network shows the impact of papers produced by I Setnikar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I Setnikar. The network helps show where I Setnikar may publish in the future.
Co-authorship network of co-authors of I Setnikar
This figure shows the co-authorship network connecting the top 25 collaborators of I Setnikar.
A scholar is included among the top collaborators of I Setnikar based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with I Setnikar. I Setnikar is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Reginster, Jean‐Yves, et al.. (1997). Sodium monofluorophosphate reduces vertebral fractures in moderate postmenopausal osteoporosis. Open Repository and Bibliography (University of Liège).3 indexed citations
Noack, W., Michael J. M. Fischer, Kenneth Forster, Lucio C. Rovati, & I Setnikar. (1994). Glucosamine sulfate in osteoarthritis of the knee. Osteoarthritis and Cartilage. 2(1). 51–59.146 indexed citations
8.
Setnikar, I, et al.. (1993). Effects of meal on the pharmacokinetics of fluoride from oral monofluorophosphate.. PubMed. 43(5). 590–5.6 indexed citations
9.
Setnikar, I & Hans H. Maurer. (1990). Relative bioavailability of fluoride from monofluorophosphate tablets after single oral administration.. PubMed. 40(3). 323–8.1 indexed citations
10.
Setnikar, I, et al.. (1989). Pharmacological characterisation of the smooth muscle antispasmodic agent tiropramide.. PubMed. 39(9). 1114–9.4 indexed citations
11.
Setnikar, I, et al.. (1989). Antispasmodic activity of tiropramide.. PubMed. 39(9). 1109–14.3 indexed citations
Bizzarri, D, et al.. (1979). Pharmacological study of a new non-steroidal anti-inflammatory drug: protacine (CR 604).. PubMed. 29(8). 1116–22.6 indexed citations
15.
Setnikar, I, et al.. (1975). Flavoxate and 3-methylflavone-8-carboxylic acid. Assay methods in blood and urine, plasma-red cells repartition and stability.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 25(11). 1707–9.7 indexed citations
Setnikar, I, et al.. (1961). The coronary vasodilator activity of morpholinoethyl-3-methyl-flavone-8-carboxylate in comparison with that of other coronary vasodilators.. PubMed. 131. 187–208.2 indexed citations
Setnikar, I, Angelo Taglietti, & Emilio Agostoni. (1957). [Kinetics of the pleural fluid studied by means of albumin labeled with I131].. PubMed. 33(10-11). 1650–3.2 indexed citations
20.
Meschia, Giacomo, et al.. (1953). Specific dynamic action of protein during muscular work.. 37. 44–54.1 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.